Merck KGaA: adjusted EPS up 20.5% in 2020
(CercleFinance.com) - Merck KGaA's sales reached 17.
5 billion euros in 2020, up 8.6% compared to 2019.
At the same time, adjusted EBITDA increased by 18.6% to 5.2 billion euros. Adjusted EPS came in at 6.7 euros, above the consensus and 20.5% higher than in 2019.
Indeed, 2020 was characterised by unprecedented turbulence. However, despite the circumstances of the pandemic, the group resolutely pursued its strategy and achieved superb business results, it said.
Merck KGaA says that it will propose a dividend of 1.4 per share to shareholders.
Copyright (c) 2021 CercleFinance.com. All rights reserved.
5 billion euros in 2020, up 8.6% compared to 2019.
At the same time, adjusted EBITDA increased by 18.6% to 5.2 billion euros. Adjusted EPS came in at 6.7 euros, above the consensus and 20.5% higher than in 2019.
Indeed, 2020 was characterised by unprecedented turbulence. However, despite the circumstances of the pandemic, the group resolutely pursued its strategy and achieved superb business results, it said.
Merck KGaA says that it will propose a dividend of 1.4 per share to shareholders.
Copyright (c) 2021 CercleFinance.com. All rights reserved.